Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

Jan 12, 2015
GenMark Announces Completion of ePlex™ Development and Preliminary Q4 Financial Results

Dec 30, 2014
GenMark Diagnostics to Present at the 2015 J.P. Morgan Healthcare Conference

View all releases »

Events

Feb 24, 2015 at 4:30 PM ET
GenMark Diagnostics Fourth Quarter Earnings

Jan 13, 2015 at 9:30 AM PT
2015 J.P. Morgan Healthcare Conference

View all events »

Related Links

Stock Quote
Price:
13.15
Change:
+ 0.06
Day High:
13.24
Day Low:
12.95
Volume:
38,000
NASDAQ
GNMK
4:00 PM ET on Jan 23, 2015
Delayed at least 20 minutes.
Provided by eSignal.